Filing Details

Accession Number:
0001628280-22-030946
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-29 16:11:12
Reporting Period:
2022-11-25
Accepted Time:
2022-11-29 16:11:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Cardiff Oncology Inc. CRDF Biological Products, (No Disgnostic Substances) (2836) 272004382
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651537 Mark Erlander C/O Cardiff Oncology, Inc.
11055 Flintkote Ave
San Diego CA 92121
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-25 10,000 $1.43 24,481 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct